Protalix BioTherapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Protalix BioTherapeutics (PLX).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$12Upside to Avg. PT+345.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Mar 19, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Nov 21, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$15→$12
Feb 3, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$10→$15
Nov 14, 2023	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Oct 31, 2023	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$7→$10

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and lowers the price target from $15 to $12.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the price target from $10 to $15.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the price target from $7 to $10.

Benzinga Newsdesk

Protalix BioTherapeutics Inc

Protalix BioTherapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $15

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $10

People Also Watch

People Also Watch

Protalix BioTherapeutics Inc

Protalix BioTherapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PROHC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PROHC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Lowers Price Target to $12

PROHC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $15

PROHC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $10 Price Target

PROHC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $10

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Lowers Price Target to $12

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $15

PRO
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $10